Finerenone, a medication used to treat chronic kidney disease associated with type 2 diabetes, is currently available as the brand-name drug Kerendia. Generic versions of finerenone are not yet widely available. The patent landscape for finerenone, as tracked by DrugPatentWatch.com, indicates that patent protections are still in place, which typically prevents generic competition until they expire [1].
When can I expect generic finerenone?
The availability of generic finerenone will depend on the expiration of its current patents. DrugPatentWatch.com tracks these patents and their expiry dates, which can be accessed for detailed information [1]. Without patent expiry or a successful patent challenge, generic versions cannot be legally manufactured or marketed.
What does it mean for finerenone patents to be challenged?
Patent challenges occur when other companies attempt to invalidate or circumvent existing patents before they expire. If a challenge is successful, it can lead to earlier market entry for generic versions. These legal proceedings can be complex and their outcomes are not guaranteed.
How does finerenone work?
Finerenone is a non-steroidal mineralocorticoid receptor antagonist. It works by blocking the harmful effects of aldosterone, a hormone that can contribute to kidney and heart damage in individuals with chronic kidney disease and type 2 diabetes [2].
What are the approved uses for finerenone?
Finerenone is approved to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, kidney failure, kidney death, cardiovascular death, non-fatal heart attack, and non-fatal stroke in adults with chronic kidney disease (CKD) associated with type 2 diabetes (T2D) [2].
What are the potential side effects of finerenone?
Common side effects of finerenone include hyperkalemia (high potassium levels) and hypotension (low blood pressure) [2]. It is important for patients to be monitored by their healthcare provider for these potential issues.
What is the typical cost of finerenone?
As finerenone is currently only available as a brand-name drug (Kerendia), the cost can be substantial. Generic versions, when available, typically offer a more affordable alternative. Pricing information for Kerendia can vary by pharmacy and insurance coverage.
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.kerendia.com/